PMS49 COST-UTILITY ANALYSIS OF LEFLUNOMIDE (ARAVA) IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)75187-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)75187-1/fulltext
Section Title :
Section Order :
1111
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75187-1&doi=10.1016/S1098-3015(10)75187-1